These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26833168)

  • 1. Common bleeding disorders affecting individuals with Hereditary Hemorrhagic Telangiectasia.
    LaBranche J; Nahirniak S; Vethanayagam D
    Clin Invest Med; 2016 Feb; 39(1):E1-6. PubMed ID: 26833168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ
    J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women.
    Zhang E; Virk ZM; Rodriguez-Lopez J; Al-Samkari H
    Blood Adv; 2024 Jun; 8(12):3166-3172. PubMed ID: 38593443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
    Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
    Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
    Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
    Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
    Ghosh K; Ghosh K
    Thromb Haemost; 2008 Jul; 100(1):162-4. PubMed ID: 18612556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia.
    Willemse RB; Mager JJ; Westermann CJ; Overtoom TT; Mauser H; Wolbers JG
    J Neurosurg; 2000 May; 92(5):779-84. PubMed ID: 10794291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy.
    Suppressa P; Pagella F; Lenato GM; Gaetani E; Serio I; Masala MS; Spinozzi G; Lizzio R; Matti E; De Silvestri A; Passali GC; Aguglia M; Crocione C; Sabbà C
    Orphanet J Rare Dis; 2021 Sep; 16(1):378. PubMed ID: 34496900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel association between high red blood cell alloimmunization rates and hereditary hemorrhagic telangiectasia.
    Zheng Y; Pollak J; Henderson K; Hendrickson JE; Tormey CA
    Transfusion; 2018 Mar; 58(3):775-780. PubMed ID: 29210083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Hemorrhagic Telangiectasia.
    Parambil JG
    Clin Chest Med; 2016 Sep; 37(3):513-21. PubMed ID: 27514597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary capillary hemangiomatosis arising in hereditary hemorrhagic telangiectasia.
    Varnholt H; Kradin R
    Hum Pathol; 2004 Feb; 35(2):266-8. PubMed ID: 14991548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Term neonate with intracranial hemorrhage and hereditary hemorrhagic telangiectasia: a case report and review of the literature.
    Delaney HM; Rooks VJ; Wolfe SQ; Sawyer TL
    J Perinatol; 2012 Aug; 32(8):642-4. PubMed ID: 22842803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
    Longacre AV; Gross CP; Gallitelli M; Henderson KJ; White RI; Proctor DD
    Am J Gastroenterol; 2003 Jan; 98(1):59-65. PubMed ID: 12526937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study.
    Donaldson JW; McKeever TM; Hall IP; Hubbard RB; Fogarty AW
    Neurology; 2015 May; 84(18):1886-93. PubMed ID: 25862798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: clinical presentation and anatomical distribution.
    Saleh M; Carter MT; Latino GA; Dirks P; Ratjen F
    Pediatr Neurol; 2013 Dec; 49(6):445-50. PubMed ID: 24080277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation.
    Edwards CP; Shehata N; Faughnan ME
    Ann Hematol; 2012 Dec; 91(12):1959-68. PubMed ID: 23053175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.